Literature DB >> 11192541

Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.

M Gorguner1, M Cerci, I Gorguner.   

Abstract

OBJECTIVE: We aimed to investigate adenosine deaminase (ADA) activity and the activities of its ADA1 and ADA2 isoenzymes in pleural effusions and also sera with different aetiological origins.
METHODOLOGY: The pleural effusions of 87 patients were examined. The patients were separated into four groups: transudates, parapneumonic, malignant, and tuberculous effusions. The cases were also designated as tuberculous or non-tuberculous group. Adenosine deaminase activity was determined by the colorimetric method described by Giusti and Galanti.
RESULTS: The intermean differences were statistically significant for total ADA, ADA1 and ADA2, except for pleural fluid ADA1 in the malignant group when compared to the tuberculous effusion group. The intermean differences between the tuberculous and non-tuberculous group were statistically significant for all three parameters except for pleural fluid and serum ADA1 activity. The sensitivities of total ADA, ADA1 and ADA2 activities for tuberculosis were 91, 57 and 93%, respectively; their specificities 89, 88 and 92%, respectively; their positive predictive values 82, 70 and 86%; and their diagnostic accuracies 89, 76 and 92%, respectively, in pleural fluid.
CONCLUSIONS: Determination of ADA and its isoenzymes can help to differentiate the causes of pleural effusion. Increased ADA2 activity is a striking marker of tuberculous effusions. In contrast, increased ADA1 activity was significantly elevated in parapneumonic effusions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11192541

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

1.  Kothari et al.: "An unusual cause of stridor: retropharyngeal cold abscess".

Authors:  Hasan Yasan; Harun Doğru
Journal:  Pediatr Surg Int       Date:  2003-12-24       Impact factor: 1.827

2.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Tuberculosis 2004: challenges and opportunities.

Authors:  Jeffrey Glassroth
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

4.  Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascites.

Authors:  Yuu Shimozuma; Takayoshi Ito; Shigeaki Ishii; Momoko Inokuchi; Manabu Uchikoshi; Miyuki Oyama; Kazumasa Hiroishi; Michio Imawari
Journal:  Clin J Gastroenterol       Date:  2009-05-13

5.  Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?

Authors:  Bojan Zarić; Vesna Kuruc; Aleksandar Milovančev; Marica Markovic; Tatjana Šarčev; Vukašin Čanak; Slobodan Pavlović
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

6.  MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes.

Authors:  Sadanand Fulzele; Ahmed El-Sherbini; Saif Ahmad; Rajnikumar Sangani; Suraporn Matragoon; Azza El-Remessy; Reshmitha Radhakrishnan; Gregory I Liou
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

7.  Exudative pleural effusion in chronic kidney disease: An aetiological dilemma.

Authors:  Gautam Ahluwalia
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

Review 8.  The Value of Adenosine Deaminase 2 in the Detection of Tuberculous Pleural Effusion: A Meta-Analysis and Systematic Review.

Authors:  Tingting Zeng; Bing Ling; Xueru Hu; Shuyan Wang; Wenliang Qiao; Lijuan Gao; Yongchun Shen; Dajiang Li
Journal:  Can Respir J       Date:  2022-09-10       Impact factor: 2.130

9.  Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Authors:  Eveline M Delemarre; Laura van Hoorn; Aik W J Bossink; Julia Drylewicz; Simone A Joosten; Tom H M Ottenhoff; Onno W Akkerman; Delia Goletti; Elisa Petruccioli; Assunta Navarra; Brigitte T A van den Broek; Sanne P A Paardekooper; Ineke van Haeften; Leo Koenderman; Jan-Willem J Lammers; Steven F T Thijsen; Regina W Hofland; Stefan Nierkens
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.